FindTrial
Sign In

A study to understand concerns about radiotherapy in blood-related cancer patients planned for radiotherapy

A mixed method study to estimate anxiety, and to assess its triggers, in patients planned for curative intent radiotherapy for haemato-lymphoid malignancies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/086421
Enrollment
80
Registered
2025-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C969- Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Dr Sangeeta Kakoti
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged above 18 years of age 2. With hematolymphoid malignancies 3. being planned for consolidative or definitive RT (conventional or conformal)

Exclusion criteria

Exclusion criteria: 1. Patients with prior history of receiving RT. 2. Patients with diagnosed anxiety disorder. 3. Patients unable to understand English, Hindi or Marathi.

Design outcomes

Primary

MeasureTime frame
Estimation of the incidence of anxiety (using HADS-A scoring) in hematolymphoid patients coming for curative intent radiotherapyTimepoint: 1 year—

Secondary

MeasureTime frame
Qualitative assessment about perspectives of patients about their upcoming radiotherapy journey, and their concerns or factors related to the same, leading to treatment-related anxiety.Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Sangeeta Kakoti

Department of Radiation Oncology, ACTREC, Tata Memorial Centre Mumbai

drsangeetakakoti@gmail.com9769938230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026